Evidence-Based Compounds for ADHD
ADHD involves dysregulation of dopamine and norepinephrine signalling in prefrontal cortex circuits governing executive function, attention, and impulse control. Research identifies several compounds with evidence for improving attention, reducing hyperactivity, and supporting dopamine/norepinephrine metabolism as adjuncts to standard care.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001